HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Direct activation of human CD8+ cytotoxic T lymphocytes by interleukin-18.

Abstract
Direct activation of human cytotoxic T lymphocytes (CTL) by interleukin (IL)-18 was observed in a system in which CTL effective against autologous tumor cells were generated. Peripheral blood mononuclear cells (PBMC) from tumor-bearing patients, after removal of natural killer (NK) cells, were cultured in a medium containing IL-1, -2, -4, and -6, with or without IL-18, and stimulated with autologous tumor cells. IL-18 increased the activity of the CTL and the proportion of autologous CD8+ T cells present after 28 days in the induction culture. When purified CD8+ T cells were cultured in the presence of IL-18 and IL-2 for 7 days, the CTL showed enhanced cytotoxic activity against autologous tumor cells. Moreover, a purified CD8+ T cell population, which did not exhibit any apparent cytotoxic activity against autologous tumor cells, displayed cytotoxic activity after 7-day incubation with IL-18. These results suggest that IL-18 may be useful to generate autologous CTL in humans and may thereby contribute to adoptive immunotherapy for tumors.
AuthorsM Kohyama, K Saijyo, M Hayasida, T Yasugi, M Kurimoto, T Ohno
JournalJapanese journal of cancer research : Gann (Jpn J Cancer Res) Vol. 89 Issue 10 Pg. 1041-6 (Oct 1998) ISSN: 0910-5050 [Print] Japan
PMID9849583 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-1
  • Interleukin-18
  • Interleukin-2
  • Interleukin-6
  • Interleukins
  • Recombinant Proteins
  • Interleukin-4
Topics
  • Adenocarcinoma
  • Carcinoma, Renal Cell
  • Cells, Cultured
  • Coculture Techniques
  • Cytotoxicity, Immunologic
  • Glioblastoma
  • Humans
  • Interleukin-1 (pharmacology)
  • Interleukin-18 (pharmacology)
  • Interleukin-2 (pharmacology)
  • Interleukin-4 (pharmacology)
  • Interleukin-6 (pharmacology)
  • Interleukins (pharmacology)
  • Kidney Neoplasms
  • Lymphocyte Activation (drug effects)
  • Neoplasms (immunology)
  • Recombinant Proteins (pharmacology)
  • Stomach Neoplasms
  • T-Lymphocytes, Cytotoxic (drug effects, immunology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: